Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

Opening Bell: March 19, 2026

XRP Treasury Evernorth Files SEC Form S-4 for Nasdaq Listing

Is Citizens Financial Stock Outperforming the Nasdaq?

Getty Images Receives Notice from NYSE Regarding Continued Listing Standard

It's called 'private credit' — and it could lead to big trouble on Wall Street